Back to search

Article

USP18 Inhibition Enhances Type I Interferon Signalling and Immune Activation in the Tumour Microenvironment of Triple-Negative Breast Cancer

2025-09-04

Abstract excerpt

Triple-negative breast cancer (TNBC) is one of the most aggressive and treatment-resistant breast cancers. Although immunotherapy has emerged as a promising treatment option, clinical benefit is limited, with only around half of patients responding, even when combined with standard chemotherapeutic agents. This limited efficacy is often attributed to immunologically “cold” tumour microenvironments (TME), which are...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
6ceec6e4-80a2-547b-8057-9f9e845dbf64
DOI
10.1101/2025.09.01.672152
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
USP18 Inhibition Enhances Type I Interferon Signalling and Immune Activation in the Tumour Microenvironment of Triple-Negative Breast CancerDOI 10.1101/2025.09.01.672152
Select a neighboring publication to make it the new centre.